Kiwi Wealth Investments Limited Partnership’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-53,661
Closed -$7.23M 43
2023
Q2
$7.23M Buy
53,661
+4,772
+10% +$700K 0.45% 65
2023
Q1
$7.79M Sell
48,889
-8,355
-15% -$1.28M 0.51% 57
2022
Q4
$9.25M Sell
57,244
-232
-0.4% -$35.6K 0.62% 47
2022
Q3
$8.8M Hold
57,476
0.61% 40
2022
Q2
$8.8M Sell
57,476
-5,580
-9% -$853K 0.61% 40
2022
Q1
$10.2M Sell
63,056
-3,928
-6% -$571K 0.55% 46
2021
Q4
$9.07M Sell
66,984
-7,277
-10% -$860K 0.43% 67
2021
Q3
$8.01M Buy
74,261
+48,744
+191% +$5.57M 0.41% 69
2021
Q2
$2.87M Hold
25,517
0.15% 155
2021
Q1
$2.76M Hold
25,517
0.16% 139
2020
Q4
$2.73M Sell
25,517
-3,933
-13% -$378K 0.16% 161
2020
Q3
$2.58M Sell
29,450
-107,521
-78% -$10.1M 0.18% 147
2020
Q2
$13.4M Buy
136,971
+2,165
+2% +$191K 1.09% 25
2020
Q1
$10.3M Buy
134,806
+69,267
+106% +$5.9M 1.03% 28
2019
Q4
$5.8M Buy
+65,539
New +$5.44M 0.43% 64
2019
Q2
Sell
-72,844
Closed -$5.87M 173
2019
Q1
$5.87M Buy
72,844
+9,707
+15% +$794K 0.53% 59
2018
Q4
$5.82M Sell
63,137
-2,764
-4% -$243K 0.61% 50
2018
Q3
$6.23M Buy
65,901
+2,871
+5% +$272K 0.59% 44
2018
Q2
$5.84M Sell
63,030
-73,057
-54% -$7.13M 0.55% 51
2018
Q1
$12.9M Buy
136,087
+13,379
+11% +$1.47M 1.27% 23
2017
Q4
$11.9M Sell
122,708
-38,255
-24% -$3.61M 1.3% 23
2017
Q3
$14.3M Buy
160,963
+15,047
+10% +$1.15M 1.72% 18
2017
Q2
$10.6M Sell
145,916
-26,376
-15% -$1.77M 0.97% 22
2017
Q1
$11.2M Buy
172,292
+105,730
+159% +$6.65M 0.92% 21
2016
Q4
$4.17M Buy
66,562
+1,456
+2% +$88.9K 0.36% 44
2016
Q3
$4.11M Buy
65,106
+176
+0.3% +$11.4K 0.35% 48
2016
Q2
$4.02M Buy
+64,930
New +$3.96M 0.39% 67
2015
Q1
Sell
-172,223
Closed -$11.3M 69
2014
Q4
$11.3M Sell
172,223
-15,079
-8% -$951K 1.12% 35
2014
Q3
$10.8M Buy
187,302
+5,742
+3% +$319K 1.01% 40
2014
Q2
$10.2M Buy
+181,560
New +$9.52M 1.05% 36

Other funds holding ABBV

Kiwi Wealth Investments Limited Partnership's ABBV Position: Q3 2023 in Review

Kiwi Wealth Investments Limited Partnership sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 53,661 shares — an estimated $7.23M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in ABBV in Q2 2014 and held it in 30 quarters. The position peaked at $14.3M in Q3 2017. 3,110 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Kiwi Wealth Investments Limited Partnership reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 53,661 AbbVie shares in Q3 2023, an estimated $7.23M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in AbbVie in Q2 2014 and held it in 30 quarters.
  • Kiwi Wealth Investments Limited Partnership's AbbVie position peaked at $14.3M in Q3 2017.
  • 3,110 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q3 2023, filed 14 Nov 2023.